Verdicts & Settlements

Our Lead Attorneys Settle Cases for National Litigation

SAN FRANCISCO, May 1, 2014 – Levin Simes LLP announced that an agreement in principle has been reached to settle approximately 20,000 claims related to vaginal mesh products sold by American Medical Systems, Inc. (AMS), a subsidiary of Endo Pharmaceuticals. These include claims of women represented by Levin Simes and several other law firms. Endo Pharmaceuticals will pay approximately $830 million for resolution of those claims.

William Levin of Levin Simes, one of the lead negotiating counsel, engaged in talks with Endo Pharmaceuticals since the fall of 2013 to create the structure and process to negotiate settlement of these claims and the claims that remain against AMS. The result is a resolution framework that allows for the categorization of claimants’ injuries based on proof of implant with an AMS product, operative reports and additional medical records with an overall dollar settlement negotiated for each firm.

“We are very happy to have helped to obtain compensation for so many women who have been injured by transvaginal mesh products, including many of our own clients. The negotiations have been difficult and complex but I would like to compliment AMS for being the first major manufacturer to step up and take responsibility for resolving the cases. We would also like to thank Judge Goodwin for his extraordinary efforts in supervising these negotiations as well as our co-negotiating counsel, Joe Rice and Henry Garrard,” said Levin.

The Honorable Joseph R. Goodwin of the Southern District of West Virginia supervised the negotiations. Joe Rice and Henry Garrard served as co-negotiating Counsel with Levin.

Levin Simes, LLP is a national products liability firm in San Francisco, California representing clients in all 50 states who have been injured by defective drugs and medical devices including transvaginal mesh, Actos, DePuy hip devices, metal on metal hips and those injured by heart attack or stroke due to Testosterone Therapy. The firm is also one of the most successful and well respected Mesothelioma and asbestos trial practices in the United States.